Skip to main content
. 2024 Nov 14;16:17588359241292272. doi: 10.1177/17588359241292272

Figure 1.

Figure 1.

Study population attrition.

aBased on the presence of ICD versions 9 and 10 codes for ovarian, fallopian tube, and/or peritoneal cancer (ICD-9: 183x, 158x; ICD-10: C56x, C57.0x, C48x) with two or more documented clinical visits.

bPatients with borderline histology were excluded.

cPatients with niraparib 2LM who did not have a non-canceled medication order for niraparib were excluded.

1L, first-line; 2L, second-line; 2LM, second-line maintenance; AS, active surveillance; ECOG, Eastern Cooperative Oncology Group; ICD, International Classification of Disease; OC, ovarian cancer; PARP, poly(ADP-ribose) polymerase; wt, wild type.